BARD1 is a company that provides BARD1, Lung cancer, RNA and more. BARD1 is headquartered in Switzerland Geneve. BARD1 was founded in 2010. and was founded by Irmgard Irminger-Finger. BARD1 has a total of 11 patents
BARD1 is a protein released in an aberrant form by cancer cells and that is used for the diagnostic of lung cancer. BARD1AG is developing a non-invasive...